|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2007
vol. 109 abstract:
Review paper
Neuro-hormonal regulation of aqueous humor dynamics as the basis of glaucoma pharmacotherapy Part I. Aqueous humor secretion
Barbara Terelak-Borys
1
,
Iwona Liberek
1
Klinika Oczna 2007, 109 (1): 60-63
Online publish date: 2007/03/23
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The aim of this article is to present current opinion on aqueous humor dynamics regulation and antiglaucoma drugs mechanisms of action. Glaucoma pharmacotherapy is based mainly on neuro-hormonal processes controlling aqueous humor dynamics. Systemic hormones as well as local hormones and autonomic nervous system mediators are involved in the processes of aqueous humor formation and drainage. Antiglaucoma medications act mainly through activation or inhibition of these systems’ receptors, helping to decrease aqueous humor production or improve aqueous humor outflow. In this article (part 1) we describe three groups of antiglaucoma medications (beta-antagonists, adrenergic agonists, carbonic anhydrase inhibitors), inhibiting the aqueous humor production and mechanisms of their hypotensive effect in the eye.
keywords:
dynamics of aqueous humor, active secretion, ultrafiltration, glaucoma pharmacotherapy, beta-blockers, adrenergic agonists, carbonic anhydrase inhibitors |
|
POLSKI
